Itching, Xerosis
Conditions
Keywords
skin regimen, moisturizer, dry skin, dry, itchy skin, skin care
Brief summary
This research is being done to evaluate the role of a regular skin care regimen comprising of a mild soap and moisturizer in improving dry skin and overall skin health. In this study, the investigators hope to learn the importance of regular skin care regimen in improving dry skin and overall skin health.
Detailed description
Dry skin is a common phenomenon and can dramatically decrease a person's quality of life as well as contribute to a wide variety of skin diseases. Skin care products hydrate the skin and breaks the dry skin cycle. While there is extensive evidence of benefits of using mild cleansers and moisturizers, much of the previous studies are limited to the effects of single cleanser or moisturizer. In this study, the investigators are going to enroll up to 100 people over the age of 18 with dry, itchy skin and they will be split into 2 groups. Participants will be randomly assigned to skin care regimen group (approximately 75% of total enrolled) and control group (approximately 25% of total enrolled). All evaluation include clinical assessments, subject questionnaires and photography will be conducted similarly in both groups. Analysis will include paired and unpaired t-tests with two-tailed p-values. Values obtained at baseline, in middle of the study and after completing the study will be compared. The difference of measure values will be compared between application group and control group. The moisturizing lotion and wash are generally very well tolerated.Rarely, they can induce a burning sensation, dryness, skin irritation, erythema, stinging, sensitization, and dermatitis. Risk events, problems, and deviations will be reported by the PI directly to the Institutional Review Boards. The investigators hope to learn the importance of regular skin care regimen in improving dry skin and overall skin health.
Interventions
OTHERskin care regimen
These participants will be asked to apply skin care regimen, the Vaseline® Moisturizer twice a day and use Dove® Soap daily for 2 weeks.
Sponsors
Johns Hopkins University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Participants must be over the age of 18 years old with dry, itchy skin; * Participant must be willing to comply with the requirements of the protocol; * Participant must have the ability to understand and communicate with the investigator; * Participant must provide informed consent.
Exclusion criteria
* Subjects who are unable to provide informed consent; * Subjects who are unable to refrain from swimming or hot tub use throughout the study duration * Subject with significant medical history or current skin diseases that the investigator feels is not safe for study participation; * Subjects who have been treated with systemic retinoids or steroids within the past month prior to entry to the study; * Subjects who have been treated with topical steroids, retinoids or other topical drugs within 2 weeks prior to entry to the study; * Recently treated or current skin diseases that would affect clinical evaluation; * Subjects who self-report that they are pregnant or nursing; * Patients with history of investigational drug use in the 30 days prior to entry into the study.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change in Total Clinical Score (TCS) Between the Final Visit and Baseline | Baseline and 3 weeks | Evaluated by blinded investigator, consists of three section; erythema (0=no erythema; 4=fiery red with oedema), scaling(0=no scaling; 3=severe scaling), and fissures scored 0-3 (0=no fissure; 3=wide cracks with hemorrhage) yield total between 0 and 10. The evaluation will be done for four sites: both lower legs and both forearms.Total Body Score (TCS) is the sum of three symptoms, i.e., erythema (0 = no erythema, 1 = slight erythema, 2 = moderate uniform redness, 3 = intense redness, 4 = fiery red with edema), scaling (0 = no scaling, 1 = fine scaling, 2 = moderate scaling, 3 = severe scaling with large flakes), and fissure (0 = no crack/fissure, 1 = fine cracks, 2 = single or multiple broader fissures, 3 = wide cracks with hemorrhage or exudation). Thus, the TCS could range from 0 to 10, with the higher scores representing more severe condition. |
| Change in Visual Dryness 5-point Severity Score for Total Body Score Between the Final Visit and the Baseline | Baseline and 3 weeks | Visual Dryness Severity (VDS) was evaluated by blinded investigator, scored on a 5-point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe, yield total between 0 and 4. The evaluation will be done for four sites: both lower legs and both forearms. Total body score is the sum of the four sites, ranging from 0 to 16 with the higher scores representing more severe dryness. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Change in Frequency of Itchy-specific Quality-of-life (ItchyQoL) Score Between the Final Visit and Baseline | Baseline and 3 weeks | Self-reported itchy related quality of life questions. Total 22 items and each item is scored as frequency. Frequency items are scored on scale of 1-5 (1 = never, 2 = rarely, 3 = sometimes, 4 = often, 5 = all the time) by four measures : Symptom with score range (6-30), Function with score range (7-35), Emotion with score range(9-45) and Overall with score range(22-110). The higher score represents more severe condition. |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Regimen Group After 1 week washout period using provided Dove® Soap without any moisturizer, participants in the skin care regimen group will receive Vaseline® Moisturizer, Dove® Soap, and application log. These participants will be asked to apply the Vaseline® Moisturizer twice a day and use Dove® Soap daily for 2 weeks. All applications should be reported in the application log by the participants. A demonstration and verbal instructions for how and where to apply the products will be provided to the subjects along with the application log for daily use. | 40 |
| Control Group After 1 week washout period using provided Dove® Soap without any moisturizer, Individuals in the control group will continue with the provided Dove® Soap for 2 weeks.
All applications should be reported in the application log by the participants. A demonstration and verbal instructions for how and where to apply the products will be provided to the subjects along with the application log for daily use. | 14 |
| Total | 54 |
Withdrawals & dropouts
| Period | Reason | FG000 | FG001 |
|---|---|---|---|
| Overall Study | Lost to Follow-up | 1 | 1 |
Baseline characteristics
| Characteristic | Control Group | Total | Regimen Group |
|---|---|---|---|
| Age, Continuous | 24 years | 28 years | 30 years |
| Race and Ethnicity Not Collected | — | 0 Participants | — |
| Region of Enrollment United States | 14 participants | 54 participants | 40 participants |
| Sex: Female, Male Female | 10 Participants | 35 Participants | 25 Participants |
| Sex: Female, Male Male | 4 Participants | 19 Participants | 15 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 39 | 0 / 13 |
| other Total, other adverse events | 0 / 39 | 0 / 13 |
| serious Total, serious adverse events | 0 / 39 | 0 / 13 |
Outcome results
Primary
Change in Total Clinical Score (TCS) Between the Final Visit and Baseline
Evaluated by blinded investigator, consists of three section; erythema (0=no erythema; 4=fiery red with oedema), scaling(0=no scaling; 3=severe scaling), and fissures scored 0-3 (0=no fissure; 3=wide cracks with hemorrhage) yield total between 0 and 10. The evaluation will be done for four sites: both lower legs and both forearms.Total Body Score (TCS) is the sum of three symptoms, i.e., erythema (0 = no erythema, 1 = slight erythema, 2 = moderate uniform redness, 3 = intense redness, 4 = fiery red with edema), scaling (0 = no scaling, 1 = fine scaling, 2 = moderate scaling, 3 = severe scaling with large flakes), and fissure (0 = no crack/fissure, 1 = fine cracks, 2 = single or multiple broader fissures, 3 = wide cracks with hemorrhage or exudation). Thus, the TCS could range from 0 to 10, with the higher scores representing more severe condition.
Time frame: Baseline and 3 weeks
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Regimen Group | Change in Total Clinical Score (TCS) Between the Final Visit and Baseline | -4 score on a scale |
| Control Group | Change in Total Clinical Score (TCS) Between the Final Visit and Baseline | -2 score on a scale |
Primary
Change in Visual Dryness 5-point Severity Score for Total Body Score Between the Final Visit and the Baseline
Visual Dryness Severity (VDS) was evaluated by blinded investigator, scored on a 5-point scale (0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe, yield total between 0 and 4. The evaluation will be done for four sites: both lower legs and both forearms. Total body score is the sum of the four sites, ranging from 0 to 16 with the higher scores representing more severe dryness.
Time frame: Baseline and 3 weeks
| Arm | Measure | Value (MEDIAN) |
|---|---|---|
| Regimen Group | Change in Visual Dryness 5-point Severity Score for Total Body Score Between the Final Visit and the Baseline | -4 score on a scale |
| Control Group | Change in Visual Dryness 5-point Severity Score for Total Body Score Between the Final Visit and the Baseline | -3 score on a scale |
Secondary
Change in Frequency of Itchy-specific Quality-of-life (ItchyQoL) Score Between the Final Visit and Baseline
Self-reported itchy related quality of life questions. Total 22 items and each item is scored as frequency. Frequency items are scored on scale of 1-5 (1 = never, 2 = rarely, 3 = sometimes, 4 = often, 5 = all the time) by four measures : Symptom with score range (6-30), Function with score range (7-35), Emotion with score range(9-45) and Overall with score range(22-110). The higher score represents more severe condition.
Time frame: Baseline and 3 weeks
| Arm | Measure | Group | Value (MEDIAN) |
|---|---|---|---|
| Regimen Group | Change in Frequency of Itchy-specific Quality-of-life (ItchyQoL) Score Between the Final Visit and Baseline | symptom | -3 score on a scale |
| Regimen Group | Change in Frequency of Itchy-specific Quality-of-life (ItchyQoL) Score Between the Final Visit and Baseline | function | -1 score on a scale |
| Regimen Group | Change in Frequency of Itchy-specific Quality-of-life (ItchyQoL) Score Between the Final Visit and Baseline | emotion | -1 score on a scale |
| Regimen Group | Change in Frequency of Itchy-specific Quality-of-life (ItchyQoL) Score Between the Final Visit and Baseline | overall | -4 score on a scale |
| Control Group | Change in Frequency of Itchy-specific Quality-of-life (ItchyQoL) Score Between the Final Visit and Baseline | overall | 0 score on a scale |
| Control Group | Change in Frequency of Itchy-specific Quality-of-life (ItchyQoL) Score Between the Final Visit and Baseline | symptom | 0 score on a scale |
| Control Group | Change in Frequency of Itchy-specific Quality-of-life (ItchyQoL) Score Between the Final Visit and Baseline | emotion | 0 score on a scale |
| Control Group | Change in Frequency of Itchy-specific Quality-of-life (ItchyQoL) Score Between the Final Visit and Baseline | function | 0 score on a scale |